Mar 2024 Articles

Articles
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
Koschinsky ML, Bajaj A, Boffa MB, et al.
Journal:
J Clin Lipidol

First published: March 29, 2024 DOI: 10.1016/j.jacl.2024.03.001
View
- Share
Articles
Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN
Reijman MD, Kusters DM, Groothoff JW, et al.
Journal:
Atherosclerosis

First published: March 27, 2024 DOI: 10.1016/j.atherosclerosis.2024.117525
View
- Share
Articles
The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
Mhaimeed O, Burney ZA, Schott SL, et al.
Journal:
Am J Prev Cardiol

First published: March 18, 2024 DOI: 10.1016/j.ajpc.2024.100649
View
- Share
Articles
Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studies
Jain V, Rifai MA, Kanaya AM, et al.
Journal:
Atherosclerosis

First published: March 17, 2024 DOI: 10.1016/j.atherosclerosis.2024.117522
View
- Share
Articles
Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study
Alonso R, Arroyo-Olivares R, Díaz-Díaz JL, et al.
Journal:
Atherosclerosis

First published: March 16, 2024 DOI: 10.1016/j.atherosclerosis.2024.117516
View
- Share
Articles
Oral PCSK9 Inhibitors
Agarwala A, Asim R, Ballantyne CM
Journal:
Curr Atheroscler Rep

First published: March 13, 2024 DOI: 10.1007/s11883-024-01199-2
View
- Share
Articles
European Lipid Guidelines and Cardiovascular Risk Estimation: Current Status and Future Challenges
3Pirillo A, Tokgözoğlu L, Catapano AL
Journal:
Curr Atheroscler Rep

First published: March 2, 2024 DOI: 10.1007/s11883-024-01194-7
View
- Share

Mar 2024 Articles

Articles

A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice

Koschinsky ML, Bajaj A, Boffa MB, et al.

Articles

Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN

Reijman MD, Kusters DM, Groothoff JW, et al.

Articles

The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better

Mhaimeed O, Burney ZA, Schott SL, et al.

Articles

Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studies

Jain V, Rifai MA, Kanaya AM, et al.

Articles

Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study

Alonso R, Arroyo-Olivares R, Díaz-Díaz JL, et al.

Articles

Oral PCSK9 Inhibitors

Agarwala A, Asim R, Ballantyne CM

Articles

European Lipid Guidelines and Cardiovascular Risk Estimation: Current Status and Future Challenges

3Pirillo A, Tokgözoğlu L, Catapano AL

Articles

A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice

Koschinsky ML, Bajaj A, Boffa MB, et al.

Share

Articles

Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN

Reijman MD, Kusters DM, Groothoff JW, et al.

Share

Articles

The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better

Mhaimeed O, Burney ZA, Schott SL, et al.

Share

Articles

Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studies

Jain V, Rifai MA, Kanaya AM, et al.

Share

Articles

Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study

Alonso R, Arroyo-Olivares R, Díaz-Díaz JL, et al.

Share

Articles

Oral PCSK9 Inhibitors

Agarwala A, Asim R, Ballantyne CM

Share

Articles

European Lipid Guidelines and Cardiovascular Risk Estimation: Current Status and Future Challenges

3Pirillo A, Tokgözoğlu L, Catapano AL

Share